possessed 22.6% volume share, ranked the 2nd largest among energy drink brands in Thailand according to the Nielsen’s final sales data to consumers. For the domestics, nonetheless, the Company still places

540 -36% EBITDA Margin (%) 9.0% 7.3% 4.7% -4.3% -2.6% 9.2% 5.9% -3.2% Net Profit 322 145 71 -78% -51% 591 216 -63% EPS (Baht/Share) (1) 0.44 0.20 0.07 -84% -65% 0.80 0.21 -74% Adjusted EBITDA(2) 323 345

selling expense to increase, 1Q2020 net profit reported at THB 335M or still increased by 14% YoY because of other income representing THB 423m recognized as a gain from selling share of SHR’s subsidiary

0.0033 per share, totaling Baht 23.36 million (5) Gain from sales of investment In 2018, The Company gained from sales of investment at the amount of Baht 42 million but there is no gain or loss from sales

2.18% 3.39% Current ratio (x) 1.04 1.02 Debt/Equity (x) 0.71 0.69 Interest-bearing debt/Equity (x) 0.34 0.36 Interest coverage (x) 6.91 13.61 Book value per share (Baht) 5.42 5.38

be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the

change in status to that of a subsidiary. This resulted in basic earnings per share of Bt0.88 for the first quarter of 2018. Total Asset Total assets as of March 31, 2018 amounted to Bt18,037 million

comparing with cash or equate with cash by 42.9 MB and increased 54.8 MB of account receivable and decreased of the inventory stocks at 0.7 MB and decreasing of the other current asset at 7.0 MB and 4.9 MB

development operations.  Administrative expenses increased by Baht 8 million due mainly to loss on exchange rate. Share of loss from investment in associate increased by Baht 6 million and this relates to the

-current assets Baht 11,860.20 million by the most of non-current assets were the land, plant and equipment in amount of Baht 9,003.79 million or 71.29 percent of total assets.  Liabilities As of December